Nolato AB (publ) - Asset Resilience Ratio
Nolato AB (publ) (NOLA-B) has an Asset Resilience Ratio of 5.19% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Nolato AB (publ) to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Nolato AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Nolato AB (publ).
Liquid Assets Composition Over Time
This chart breaks down Nolato AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Nolato AB (publ) to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr482.00 Million | 5.19% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr482.00 Million | 5.19% |
Asset Resilience Insights
- Limited Liquidity: Nolato AB (publ) maintains only 5.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Nolato AB (publ) Industry Peers by Asset Resilience Ratio
Compare Nolato AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Nolato AB (publ) (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Nolato AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.19% | Skr482.00 Million ≈ $51.87 Million |
Skr9.28 Billion ≈ $998.89 Million |
-1.77pp |
| 2024-12-31 | 6.97% | Skr675.00 Million ≈ $72.64 Million |
Skr9.69 Billion ≈ $1.04 Billion |
-0.57pp |
| 2023-12-31 | 7.54% | Skr701.00 Million ≈ $75.44 Million |
Skr9.30 Billion ≈ $1.00 Billion |
-2.61pp |
| 2022-12-31 | 10.14% | Skr1.01 Billion ≈ $109.23 Million |
Skr10.01 Billion ≈ $1.08 Billion |
-4.27pp |
| 2021-12-31 | 14.41% | Skr1.45 Billion ≈ $155.94 Million |
Skr10.05 Billion ≈ $1.08 Billion |
-3.02pp |
| 2020-12-31 | 17.43% | Skr1.51 Billion ≈ $162.93 Million |
Skr8.68 Billion ≈ $934.54 Million |
-4.85pp |
| 2019-12-31 | 22.29% | Skr1.37 Billion ≈ $147.11 Million |
Skr6.13 Billion ≈ $660.12 Million |
+3.71pp |
| 2018-12-31 | 18.58% | Skr958.00 Million ≈ $103.10 Million |
Skr5.16 Billion ≈ $554.87 Million |
+4.33pp |
| 2017-12-31 | 14.25% | Skr677.00 Million ≈ $72.86 Million |
Skr4.75 Billion ≈ $511.39 Million |
+3.52pp |
| 2016-12-31 | 10.73% | Skr421.00 Million ≈ $45.31 Million |
Skr3.92 Billion ≈ $422.29 Million |
+10.51pp |
| 2015-12-31 | 0.22% | Skr7.00 Million ≈ $753.31K |
Skr3.23 Billion ≈ $347.92 Million |
-17.53pp |
| 2009-12-31 | 17.75% | Skr375.00 Million ≈ $40.36 Million |
Skr2.11 Billion ≈ $227.39 Million |
-- |
About Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more